Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is comparing Ziprasidon with Clozapine for people with with schizophrenia and cannabis abuse/dependency will be randomized to ziprasidone or clozapine treatment. Dose of medication and frequency of administration will be flexible and adjustab.
This study is comparing CLOZAPINE with OLANZAPINE for people with A multi-centre prospective, randomized, double blind designed study examining the effectiveness and costs of clozapine compared to olanzapine in with schizophrenia or related psychotic dis. Participants receive CLOZAPINE or OLANZAPINE and complete study visits and assessments.
This study is looking at whether CLOZAPINE compared with RISPERIDONE can help people with A randomized controlled trial comparing the effect of clozapine and risperidone on cannabis craving in cannabis abusing or dependent with schizophrenia. Specific cognitive tasks will be us.
This study is looking at whether Abilify can help people with Schizophrenia. Participants receive the study medicine Abilify and complete study visits and assessments.
This study is looking at whether clozapine can help people with Schizophrenia. Participants receive the study medicine clozapine and complete study visits and assessments.
This study is comparing Abilify Maintena with Xeplion for people with First episode SZ-spectrum individuals or Adolescents, Under 18. Participants receive Abilify Maintena or Xeplion and complete study visits and assessments.
This study is comparing Evenamide with placebo for people with Chronic schizophrenia or Elderly. Participants receive Evenamide or placebo and complete study visits and assessments.
This study is looking at whether ARIPIPRAZOLE compared with RISPERIDONE can help people with First episode drug-naïve of psychosis. Participants receive one of the study medicines, such as ARIPIPRAZOLE or RISPERIDONE, and complete study visits and assessments.
This study is comparing Brexpiprazole with placebo for people with Schizophrenia or Adolescents, Under 18. Participants receive Brexpiprazole or placebo and complete study visits and assessments.
This study is comparing Pimavanserin with placebo for people with Schizophrenia. Participants receive Pimavanserin or placebo and complete study visits and assessments.
This study is looking at whether Sertindol compared with Risperidon can help people with schizophrenic and healthy controls. Participants receive one of the study medicines, such as Sertindol or Risperidon, and complete study visits and assessments.
This study is looking at whether Pimavanserin can help people with Schizophrenia. Participants receive the study medicine Pimavanserin and complete study visits and assessments.
This study is looking at whether None yet can help people with Schizophrenia. Participants receive the study medicine None yet and complete study visits and assessments.
This study is comparing QUETIAPINE with FLUPENTIXOL for people with schizophrenia. Participants receive QUETIAPINE or FLUPENTIXOL and complete study visits and assessments.
This study is comparing ACETYLCYSTEINE with placebo for people with with early onset psychotic episodes or Adolescents, Under 18. Participants receive ACETYLCYSTEINE or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with attenuated psychosis syndrome or Adolescents, Under 18. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Human normal immunoglobulin with placebo for people with Antibody associated Psychosis or Elderly. Participants receive Human normal immunoglobulin or placebo and complete study visits and assessments.
This study is comparing Cannabidiol (CBD) with placebo for people with Parkinson's disease psychosis or Elderly. Participants receive Cannabidiol (CBD) or placebo and complete study visits and assessments.
This study is looking at care and outcomes for people with Individuals at Ultra High Risk for Psychosis or Adolescents, Under 18. Some participants may receive placebo instead of the study treatment, and direct benefit is not guaranteed.
This study is comparing Trospium chloride with placebo for people with Psychosis Associated with Alzheimer’s Disease Dementia or Elderly. Participants receive Trospium chloride or placebo and complete study visits and assessments.
This study is comparing Pimavanserin with placebo for people with Hallucinations and Delusions Associated With Dementia-related Psychosis or Elderly. Participants receive Pimavanserin or placebo and complete study visits and assessments.
This study assessed the safety and pharmacology of SEP-380135 in adults living with schizophrenia or a major depressive episode linked to bipolarity or major depressive disorder. The registry now lists the study as completed.
This feasibility trial is preparing to test psychodynamic interpersonal therapy for people experiencing psychosis. The ISRCTN record lists it as not yet recruiting.
This study will test Social Recovery Therapy for people living with psychosis and social disability. The ISRCTN record shows it as not yet recruiting.
This EU CTR study is testing sodium oxybate for catatonia in adults living with depression, bipolarity, or psychotic disorders. The registry page currently marks the Dutch protocol as transitioned, which the app maps to ongoing.